Taconic Capital Advisors’s St Jude Medical STJ Stock Holding History

Taconic Capital Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,500,000	Closed	-$120M	–	42
2016 Q4	$120M	Buy	1,500,000 +200,000	+15%	+$15.9M	16.66%	2
2016 Q3	$104M	Buy	1,300,000 +464,878	+56%	+$37.5M	12.82%	2
2016 Q2	$65.1M	Buy	+835,122	New	+$59.5M	4.89%	6

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Taconic Capital Advisors's STJ Position: Q1 2017 in Review

Taconic Capital Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,500,000 shares — an estimated $120M sold.

Taconic Capital Advisors first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $120M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Taconic Capital Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Taconic Capital Advisors sold 1,500,000 St Jude Medical shares in Q1 2017, an estimated $120M.
Taconic Capital Advisors first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
Taconic Capital Advisors's St Jude Medical position peaked at $120M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Taconic Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.